SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Epigral informs about institutional investors meet

19 Sep 2024 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Epigral has informed that the Company is having meeting with Institutional Investors through a Non-Deal Roadshow Non-Deal Roadshow organized by Emkay Global Financial Services from 24th September, 2024 to 25th September, 2024 on a One-on-One basis in Singapore. The latest Earnings Presentation and Corporate Presentation that may be discussed has already been placed on the website of the Company: www.epigral.com. No unpublished price sensitive information will be shared/discussed in the meeting with the Investors. 

The above information is a part of company’s filings submitted to BSE.

Epigral Share Price

1203.25 6.65 (0.56%)
30-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3640.10
Tata Chemicals 809.45
SRF 2519.20
Pidilite Inds. 1375.55
Deepak Nitrite 1736.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×